Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's

Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's

Objectives: Two of the most common neurodegenerative diseases are Alzheimer's disease and Parkinson's disease. The available treatments for the conditions are few and frequently insufficient to stop their progression. Because of possible neuroprotective, anti-oxidant, anti-apoptotic, neuro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahsas Goyal, Anshika Kumari, Aanchal Verma, Vandana Chaudhary, Prince Pathak, Harlokesh Narayan Yadav
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Brain Disorders
Subjects:	Alzheimer's disease Honokiol Magnolia officinalis Neurodegeneration Parkinson's disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666459325000289
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Repurposing old natural compounds to target new pathogens: honokiol and magnolol against Candida auris
by: Mihai Mares, et al.
Published: (2024-12-01)

Integrative analyses of the transcriptome and metabolome reveal comprehensive mechanisms of monolignol biosynthesis in response to bioclimatic factors in Magnolia officinalis
by: Mingxin Zhong, et al.
Published: (2024-12-01)

Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases
by: Xian Lin, et al.
Published: (2025-04-01)

Enhanced penetration and biofilm eradication by sophorolipid micelles encapsulating Honokiol: a comprehensive solution for biofilm-associated lung infections
by: Shiyu Lin, et al.
Published: (2025-02-01)

Polymer-Free Electrospinning of β-Cyclodextrin–Oligolactide for Magnolol and Honokiol Pharmaceutical Formulations
by: Diana-Andreea Blaj, et al.
Published: (2025-01-01)

Honokiol inhibits human osteosarcoma MG63 cell migration by upregulating FTO and Smad6 to promote autophagy
by: Jian Wu, et al.
Published: (2024-12-01)

Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS‐mutant melanoma
by: Abdullah Al Emran, et al.
Published: (2019-03-01)

Honokiol protects against diabetic retinal microvascular injury via sirtuin 3-mediated mitochondrial fusion
by: Jiemei Shi, et al.
Published: (2024-10-01)

Evaluation of the therapeutic effects of the topical and systemic forms of Honokiol in 5-fluorouracil-induced oral mucositis model in rats
by: Ayse Ozcan Kucuk, et al.
Published: (2025-06-01)

Honokiol ameliorates reserpine-induced fibromyalgia through antioxidant, anti-inflammatory, neurotrophic, and anti-apoptotic mechanisms
by: Suzan A. Khodir, et al.
Published: (2025-07-01)

Network Pharmacology, Molecular Docking, and Molecular Dynamics Analysis of Honokiol against Triple-negative Breast Cancer
by: Hassan H. Alhassan
Published: (2024-12-01)

Sirtuin-3 activation by honokiol attenuated anesthesia/surgery-induced cognitive impairment and neuronal ferroptosis via inhibiting mitochondrial GPX4 acetylation
by: Lian Zeng, et al.
Published: (2025-06-01)

Subinhibitory concentrations of Honokiol reduce α-Hemolysin (Hla) secretion by Staphylococcus aureus and the Hla-induced inflammatory response by inactivating the NLRP3 inflammasome
by: Na Guo, et al.
Published: (2019-01-01)

Effect and mechanism of Magnolia officinalis pharmacopuncture for treating localized fat via network pharmacology and experimental study
by: Won Jun Choi, et al.
Published: (2023-06-01)

Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells
by: Yang Liu, et al.
Published: (2024-12-01)

Magnolia rzedowskiana (Magnoliaceae), una especie nueva de la sección Macrophylla de la parte central de la Sierra Madre Oriental, México
by: José Antonio Vázquez-García, et al.
Published: (2015-07-01)

MaxEnt-based evaluation of climate change effects on the habitat suitability of Magnolia officinalis in China
by: Jun Ren, et al.
Published: (2025-07-01)

Magnolia officinalis enhanced immune responses and the resistance to Vibrio harveyi infection in pearl gentian groupers
by: Yilin Zhang, et al.
Published: (2025-06-01)

Neurodegeneration: A Tale of Microbes and Neurons
by: Octavian Costin IOGHEN, et al.
Published: (2025-03-01)

Editorial: Olfactory dysfunction in neurodegenerative diseases
by: Debanjan Dasgupta, et al.
Published: (2025-05-01)

SIRT1 and SIRT2: emerging targets in neurodegeneration
by: Gizem Donmez, et al.
Published: (2013-02-01)

Is gut microbiota associated with Parkinson’s disease?
by: A. V. Tyakht, et al.
Published: (2017-01-01)

Gut dysbiosis as a potential driver of Parkinson’s and Alzheimer’s disease pathogenesis
by: Jacob M. Pfaffinger, et al.
Published: (2025-08-01)

Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions
by: Julia Doroszkiewicz, et al.
Published: (2025-04-01)

Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
by: Enzo Pereira de Lima, et al.
Published: (2025-02-01)

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies
by: Muhammad Abu Talha Safdar Hashmi, et al.
Published: (2024-12-01)

ANXA2 Protein and Its Role in Neurodegeneration Processes
by: Suzanna A. Partevian, et al.
Published: (2025-03-01)

Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging
by: Monokesh K. Sen, et al.
Published: (2025-07-01)

Assessment of quality in volatile oil from three basic sources of Xinyi from Hubei by anatomy, GC-MS, and chemometric methods
by: Xiaopei Wu, et al.
Published: (2025-02-01)

Contribución a las Magnoliaceae de Colombia, III
by: Lozano Contreras Gustavo
Published: (1975-09-01)

Metabolic Syndrome and Parkinson’s Disease: Two Villains Join Forces
by: Lucas Udovin, et al.
Published: (2025-06-01)

Editorial: 15 years of frontiers in neuroanatomy: the origin of Parkinson's disease
by: Barbara Falquetto, et al.
Published: (2025-07-01)

Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy
by: David J. Rademacher, et al.
Published: (2025-06-01)

Correction: Editorial: 15 years of frontiers in neuroanatomy: the origin of Parkinson's disease
by: Barbara Falquetto, et al.
Published: (2025-07-01)

Relationship Between Depression and Neurodegeneration: Risk Factor, Prodrome, Consequence, or Something Else? A Scoping Review
by: Dario Papa, et al.
Published: (2025-04-01)

Gut-Brain Axis-Based Polygala Tenuifolia and Magnolia Officinalis Improve D-gal-Induced Cognitive Impairment in Mice Through cAMP and NF-κB Signaling Pathways
by: Yang D, et al.
Published: (2025-03-01)

Parkinson&rsquo;s disease managing reversible neurodegeneration
by: Hinz M, et al.
Published: (2016-04-01)

A prospective study of cognitive impairment in Parkinson’s disease: clinical, neuropsychological, and neuroimaging correlates
by: Ahmed A. Gaballa, et al.
Published: (2025-06-01)

Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
by: Filip Fredlund, et al.
Published: (2025-04-01)

A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage
by: Silvia Zini, et al.
Published: (2025-09-01)